Bosh sahifaUTHR • NASDAQ
add
United Therapeutics Corp
Yopilish kursi
437,33 $
Kunlik diapazon
432,53 $ - 446,08 $
Yillik diapazon
266,98 $ - 479,50 $
Bozor kapitalizatsiyasi
19,15 mlrd USD
Oʻrtacha hajm
713,84 ming
Narx/foyda
16,84
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 799,50 mln | 6,76% |
Joriy xarajat | 309,30 mln | 20,07% |
Sof foyda | 338,70 mln | 9,58% |
Sof foyda marjasi | 42,36 | 2,64% |
Har bir ulushga tushum | 7,16 | 1,25% |
EBITDA | 411,20 mln | -3,77% |
Amaldagi soliq stavkasi | 22,67% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,77 mlrd | -16,80% |
Jami aktivlari | 7,35 mlrd | 3,20% |
Jami passivlari | 760,90 mln | -25,56% |
Umumiy kapital | 6,59 mlrd | — |
Tarqatilgan aksiyalar | 43,06 mln | — |
Narxi/balansdagi bahosi | 2,85 | — |
Aktivlardan daromad | 12,76% | — |
Kapitaldan daromad | 14,14% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 338,70 mln | 9,58% |
Operatsiyalardan naqd pul | 562,10 mln | 49,02% |
Sarmoyadan naqd pul | 140,90 mln | 222,63% |
Moliyadan naqd pul | -956,00 mln | -1 391,42% |
Naqd pulning sof oʻzgarishi | -253,00 mln | -227,65% |
Boʻsh pul | 157,44 mln | -36,60% |
Haqida
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
Tashkil etilgan
1996
Sayt
Xodimlar soni
1 305
